Effect of high-intensity interval training in physiotherapy primary care for patients with inflammatory arthritis: the ExeHeart randomised controlled trial.

Arthritis, Psoriatic Arthritis, Rheumatoid Cardiovascular Diseases Physical Therapy Modalities Spondylitis, Ankylosing

Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 27 06 2023
accepted: 25 12 2023
medline: 20 1 2024
pubmed: 20 1 2024
entrez: 19 1 2024
Statut: epublish

Résumé

To assess the effect of high-intensity interval training (HIIT) delivered in physiotherapy primary care on the primary outcome of cardiorespiratory fitness (CRF) in patients with inflammatory arthritis (IA). Additionally, to explore the effects of HIIT on secondary outcomes, including cardiovascular disease (CVD) risk factors and disease activity. Single-blinded randomised controlled trial with 60 patients randomly assigned to either a control group receiving usual care or an exercise group receiving usual care and 12 weeks of individualised HIIT at 90%-95% peak heart rate. Outcomes were assessed at baseline, 3 months and 6 months post baseline and included CRF measured as peak oxygen uptake (VO Intention-to-treat analysis demonstrated a significant between-group difference in VO After 12 weeks of supervised HIIT delivered in physiotherapy primary care, patients with IA demonstrated a favourable improvement in CRF, with sustained effects at 6-month follow-up. NCT04922840.

Identifiants

pubmed: 38242550
pii: rmdopen-2023-003440
doi: 10.1136/rmdopen-2023-003440
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04922840']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: KRN has received lecture honoraria from UCB. AGS has received lecture honoraria from Merck/Schering-Plough, BMS, UCB, Pfizer/Wyeth, Sanofi, Novartis, Pfizer and Lilly and is secretary of ESC Cardiovascular Pharmacotherapy working group.

Auteurs

Kristine Røren Nordén (KR)

Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway kristineroren.norden@diakonsyk.no.
Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway.

Anne Grete Semb (AG)

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

Hanne Dagfinrud (H)

Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway.

Jonny Hisdal (J)

Department of Vascular Surgery, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Joseph Sexton (J)

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

Camilla Fongen (C)

Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway.

Emilie Bakke (E)

Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway.

Sigrid Ødegård (S)

Norwegian National Unit for Rehabilitation for Rheumatic Patients with Special Needs, Diakonhjemmet Hospital, Oslo, Norway.

Jon Skandsen (J)

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

Thalita Blanck (T)

Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.

George S Metsios (GS)

Department of Nutrition and Dietetics, University of Thessaly, Volos, Greece.

Anne Therese Tveter (AT)

Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Health Services Research and Innovation Unit, Diakonhjemmet Hospital, Oslo, Norway.
Faculty of Health Sciences, Institute of Rehabilitation Science and Health Technology, Oslo Metropolitan University, Oslo, Akershus, Norway.

Classifications MeSH